SAMBROOK PHARMACEUTICAL S.A.REGISTERED OFFICE: MUNICIPALITY ASPROPYRGOS, ATTICA
MINISTRY OF DEVELOPMENT – GENERAL SECRETARY OF COMMERCE
(G.E.MI. NO 7164401000 – Athens Chamber of Commerce & Industry)
Sambrook

The company provides services in the pharmaceutical and parapharmaceutical sector and produces / trades pharmaceutical products.

COMPANY CAPITAL: € 2.133.000

SHARΕHOLDER STRUCTURE %
ELGEKA S.A. 95,88%
Helen E. Metsoviti 3,67%
Alexander G. Katsiotis 0,45%

 

BOARD OF DIRECTORS
Alexander G. Katsiotis Chairman
Helen E. Metsoviti Vice Chairman & Managing Director
Aris S. Chatzatourian Member
Vasiliki K. Gatziyanni Member

 

FINANCIAL HIGHLIGHTS 2022 – 2021 ACCORDING TO I.F.R.S.

IN EURO

2022 2021
Sales
Gross Profit / (loss)
Profit / (loss) before taxes, financing, investing activities & depreciation
 2.207,56
 (10.030,75)
Profit / (loss) before taxes, financing & investing activities
 2.207,56
 (10.030,75)
Profit / (loss) before taxes
 2.148,61
 (10.041,89)
Profit / (loss) after taxes
 (1.865,54)
 (10.706.,76)
Shareholders´ Equity
 170.764,10
172.629,64

ADDRESS:
«Imeros Topos» Area
19300 Aspropyrgos
Tel.: +30 210 28 48 758
Fax : +30 210 28 14 308